Improving growth of infants with congenital heart disease using a consensus-based nutritional pathway

Luise V Marino1, Mark J Johnson2, Natalie J Davies3

  • 1Department of Dietetics/ SLT, University Hospital Southampton NHS Foundation Trust, SO16 6YD, UK; NIHR Biomedical Research Centre Southampton, University Hospital Southampton NHS Foundation Trust, Southampton, S016 6YD, UK; School of Health Sciences, University of Southampton, UK.

Insights

A pre-operative nutritional pathway improved growth in infants with congenital heart disease (CHD). This intervention also significantly reduced paediatric-intensive care unit length of stay (PICU-LOS), suggesting better clinical outcomes.

Area of Science:

  • Pediatric Cardiology
  • Nutritional Science
  • Critical Care Medicine

Background:

  • Infants with congenital heart disease (CHD) frequently experience growth failure before surgery.
  • Pre-operative growth failure in CHD is linked to longer paediatric-intensive care unit stays (PICU-LOS) and increased post-operative complications.
  • Optimizing nutritional status pre-operatively is crucial for improving outcomes in these vulnerable infants.

Purpose of the Study:

  • To evaluate the impact of a consensus-based, pre-operative nutritional pathway on growth in infants with CHD.
  • To assess the effect of this nutritional intervention on clinical outcomes, including PICU-LOS.
  • To determine if multidisciplinary team support within the nutritional pathway enhances patient management.

Main Methods:

  • A single-centre prospective pilot study compared an intervention group (n=44) with a historic control group (n=38).
  • The intervention involved a pre-operative nutritional pathway with weekly dietitian contact for high-risk infants, focusing on weight gain and feeding support.
  • Growth (weight-for-age z-score [WAZ] and height-for-age z-score [HAZ]) and PICU-LOS were measured at 4 and 12 months of age.

Main Results:

  • The intervention group showed improved weight-for-age z-score (WAZ) at 12 months compared to controls (p=0.03).
  • Height-for-age z-score (HAZ) was significantly better in the intervention group at 12 months (p=0.04).
  • Paediatric-intensive care unit length of stay (PICU-LOS) was significantly reduced in the intervention group (8.2 days vs. 18.3 days, p=0.006).

Conclusions:

  • A pre-operative nutritional pathway effectively maintained overall weight and improved growth in infants with CHD.
  • The intervention led to a significant reduction in PICU-LOS, potentially due to improved nutritional status.
  • This pathway, supported by a multidisciplinary team, demonstrates promise for enhancing clinical outcomes in pediatric cardiac surgery patients.
Abstract

Related Concept Videos

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
585
Parentral Nutrition: Centeral and Peripheral Parental Nutrition01:27

Parentral Nutrition: Centeral and Peripheral Parental Nutrition

Parenteral Nutrition (PN) delivers essential nutrients directly into the bloodstream, bypassing the digestive system. It is commonly used for individuals with severe digestive disorders or conditions that prevent normal nutrient absorption.
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...
660
Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding01:15

Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding

Enteral nutrition encompasses various methods of delivering nutrition directly to the gastrointestinal (GI) tract, bypassing traditional oral intake. It is particularly beneficial for patients who cannot eat by mouth but have a functioning digestive system. Key methods include nasointestinal feeding, gastrostomy, and jejunostomy, each suited to different clinical scenarios based on the patient's needs and condition.
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube...
728
Enteral Nutrition I: Orogastric and Nasogastric Feeding01:26

Enteral Nutrition I: Orogastric and Nasogastric Feeding

Enteral nutrition delivers nutrients directly to the stomach or small intestine through a tube. This method is appropriate for patients who cannot eat but still have a functioning digestive system. It is also beneficial for individuals with swallowing difficulties, anorexia, malabsorption, or those who have undergone gastrointestinal (GI) surgery.
Orogastric (OG) and nasogastric (NG) feeding are two standard methods used for enteral nutrition. Enteral nutrition is often preferred over...
1.1K
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
269
Role of Hematopoietic Growth Factors01:28

Role of Hematopoietic Growth Factors

Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
3.0K